header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-161027-2
Fish name: s705Tg
Genotype: s705Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by s705Tg
No data available
GENE EXPRESSION
Gene expression in s705Tg
Reporter gene expression No data available
PHENOTYPE
Phenotype in s705Tg
Phenotype Conditions Figures
liver ab5-akt labeling decreased amount, abnormal chemical treatment: sirolimus Fig. 6 from Cox et al., 2016
liver ab9-rps6 labeling decreased amount, abnormal chemical treatment: sirolimus Fig. 6 from Cox et al., 2016
liver ab5-akt labeling increased amount, abnormal chemical treatment: methionine sulfoximine Fig. 6 from Cox et al., 2016
liver ab9-rps6 labeling increased amount, abnormal chemical treatment: methionine sulfoximine Fig. 6 from Cox et al., 2016
liver glulb expression increased amount, abnormal standard conditions Fig. 2 from Cox et al., 2016
liver ccn1l2 expression increased amount, abnormal standard conditions Fig. 2 from Cox et al., 2016
liver amotl2b expression increased amount, abnormal standard conditions Fig. 2 from Cox et al., 2016
liver ccn2a expression increased amount, abnormal standard conditions Fig. 2 from Cox et al., 2016
liver glula expression increased amount, abnormal standard conditions Fig. 2 from Cox et al., 2016
liver increased mass, abnormal control Fig. 7 from Cox et al., 2016
liver size, ameliorated chemical treatment: methionine sulfoximine Fig. 7 from Cox et al., 2016
liver cell population proliferation increased occurrence, abnormal control Fig. 7 from Cox et al., 2016
liver cell population proliferation occurrence, ameliorated chemical treatment: methionine sulfoximine Fig. 7 from Cox et al., 2016
liver glutamate-ammonia ligase activity increased occurrence, abnormal standard conditions Fig. 4Fig. 7 from Cox et al., 2016
liver glutamate-ammonia ligase activity occurrence, ameliorated chemical treatment: methionine sulfoximine Fig. 7 from Cox et al., 2016
liver nucleotide biosynthetic process increased occurrence, abnormal control Fig. 7 from Cox et al., 2016
liver nucleotide biosynthetic process occurrence, ameliorated chemical treatment: methionine sulfoximine Fig. 7 from Cox et al., 2016
whole organism paics expression decreased amount, abnormal control Fig. S4 from Weger et al., 2018

CITATIONS  (2)